Budesonide Treatment of Professional Athletes and Anti-doping Testing--case Studies.

@article{Kaliszewski2016BudesonideTO,
  title={Budesonide Treatment of Professional Athletes and Anti-doping Testing--case Studies.},
  author={Paweł Kaliszewski and Danuta Kończak and Piotr Chołbiński and Mariola Wicka and Dorota Michalak and Dorota Kwiatkowska and Sylwia Lewandowska-Pachecka and Jacek Namieśnik and Andrzej Pokrywka},
  journal={Acta poloniae pharmaceutica},
  year={2016},
  volume={73 1},
  pages={229-37}
}
According to the World Anti-Doping Agency (WADA) Prohibited List, glucocorticosteroids are prohibited in competition and only when administered by oral, intravenous, intramuscular or rectal routes. Up to now, in order to differentiate whether glucocorticosteroids were administered by one of the prohibited routes or not, a specific reporting limit for urinary concentrations of parent compounds and their metabolites was established at 30 ng/mL. Additionally, the new specific regulation starting… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

From This Paper

Topics from this paper.

Similar Papers

Loading similar papers…